Nocreatine does not block semaglutide's appetite-suppressing or metabolic effects
Tirzepatide adds a GIP receptor agonist component, but the gastric-motility effect is similar in clinical practice [1][2]
A recent study showed that patients without diabetes who were taking Victoza in combination with a healthy diet and regular exercise lost an average of Trusted Source A Randomized, Controlled Trial of 3 Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP
doi:10.1016/j.mri.2008.06.002
Adv Gerontol , 2005 15(3):28-36 Anisimov VN et al
This guide walks you through exactly how the conversion from tirzepatide to semaglutide works: who should consider it, why, the dosing transition process, what side effects to expect, and how to maintain your weight loss and blood sugar progress throughout